Microglia in neurodegeneration: molecular aspects

Area of Science:

• Neuroscience
• Immunology
• Molecular Biology

Background:

• Central nervous system (CNS) inflammation is implicated in injuries and neurodegenerative diseases like Alzheimer's, Parkinson's, and Multiple Sclerosis.
• Brain inflammation exhibits distinct pathways and kinetics compared to peripheral inflammation due to inherent immunosuppression.
• Microglia, the primary immune cells in the brain, are key to understanding CNS inflammatory responses.

Purpose of the Study:

• To elucidate the molecular mechanisms governing immune reactions within brain tissue.
• To explore antigen presentation by microglia, the brain's professional antigen-presenting cells.
• To identify potential molecular targets for therapeutic interventions in neurological disorders.

Main Methods:

• Culturing microglia to study brain-specific immune responses.
• Analyzing the expression and regulation of pro- and anti-inflammatory cytokines.
• Summarizing the induction and regulation of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS).

Main Results:

• Antigen presentation mechanisms in microglia are a primary focus.
• Regulation of key inflammatory mediators like cytokines, COX-2, and iNOS is detailed.
• Intracellular signaling pathways and transcription factor activation are highlighted as potential therapeutic targets.

Conclusions:

• Current molecular data on brain inflammation is insufficient for comprehensive understanding.
• Further research into molecular events is essential for developing specific therapies for brain disorders.
• Neurotrophins and other growth factors may play a significant role in modulating CNS inflammation.